Antibiotic resistance in the NICU

Area of Science:

• Neonatal Medicine
• Infectious Diseases
• Pharmacology

Background:

• Antimicrobial therapy is crucial in the neonatal intensive care unit (NICU).
• Newborns are highly vulnerable to infections with rapid, multisystem dissemination.
• Clinical symptoms of infection in newborns lack specificity, necessitating early empirical treatment.

Purpose of the Study:

• To outline the rationale for early empiric antimicrobial treatment in neonates.
• To describe the principles guiding antibiotic selection based on exposure environment in neonatal sepsis.

Main Methods:

• Review of current practices in neonatal antimicrobial therapy.
• Analysis of factors influencing antibiotic choice in neonatal intensive care units.

Main Results:

• Early empiric antibiotic treatment is standard practice in NICUs.
• Antibiotic selection is stratified based on the presumed source of infection (community/maternal vs. hospital-acquired).
• Treatment decisions are made prior to definitive laboratory results.

Conclusions:

• Empirical antimicrobial therapy is essential for vulnerable neonates.
• Tailoring antibiotic choice to the likely exposure environment improves management of neonatal infections.
• Prompt treatment initiation is critical due to the severity of neonatal sepsis.